Duane Mitchell, Photo Credits: Mindy C. Miller


Neuro team mobilizes immune system against tumors
By Michelle Koidin Jaffee

Elias Sayour spent years working toward becoming a pediatric oncologist so he could help kids fight cancer. He always imagined taking care of patients; he didn’t think research was really his thing.

But as a fellow in training, Sayour was struck — overwhelmed, really — by two aspects of his work: One was the toxicity of current treatments and the toll they took, with young children suffering the effects of systemic chemotherapy and radiation on their developing brains and surgeries that invariably removed portions of brain tissue along with tumors.

The other was that the therapy itself would sometimes kill by causing an infection or other medical issue.

Sayour was not sure he could continue on this path.

“Seeing it day-in and day-out, seeing these children go through the after-effects of treatment, was something I had a very hard time with,” says Sayour. “Even when we cured these patients, it came at such a cost.”

When a colleague asked about his focus for the research portion of his fellowship, Sayour said he wished there were something like a cancer vaccine — unaware such a thing was in development right where he was, at Duke University. His colleague told him, “You have to meet this guy, Duane Mitchell.”

“I met Dr. Mitchell,” Sayour says, “and he just spoke a completely different language. He said exactly what I wanted to hear: ‘This is unacceptable, we need to do something about it, we need to attack cancer in a focused, targeted way that spares normal tissue.’”

Sayour went on to do his research under Mitchell, whose focus was on developing techniques to fight brain cancer using immunotherapy, or prompting a patient’s own immune system to target malignant tumor cells.

Elias Sayour is striving to formulate vaccines that can reprogram the immune system to combat cancer. Photo Credits: Mindy C. Miller

Now, Sayour has joined Mitchell in his burgeoning Brain Tumor Immunotherapy Program at the University of Florida. In just three years since Mitchell moved from Duke to UF, he has built a team that is attracting national attention.

This year, Mitchell and his team were recognized nationally for outstanding achievement in clinical research. Glioblastoma is the deadliest brain cancer in adults, with an average survival time of 15 to 18 months. The research conducted at UF and Duke has shown that patients who received an enhanced cancer vaccine had a significant improvement in overall survival length. The resulting paper was named by the Clinical Research Forum as one of the top 10 papers in clinical and translational science in all of U.S. scientific literature in 2015.

That accomplishment was the culmination of years and years of work, Mitchell says — lab work, preclinical work, animal models, a first-in-human clinical trial and follow-up care.

“Thinking about the number of people who worked together and contributed to that achievement, it was so nice to have it recognized,” he says.

His team believes it is only a start.

Their program, which is part of the Preston A. Wells Jr. Center for Brain Tumor Therapy at UF (co-directed by Mitchell and neurosurgery Chair William A. Friedman), is now launching a large, phase 2 first-in-human trial to confirm the benefits of the cancer vaccine. With funding from the National Cancer Institute for a five-year study, they will enroll 120 glioblastoma patients in the randomized trial.

Moreover, Mitchell’s program is known for its focus on pediatric cancer as well as adult cancer. Mitchell is also leading an immunotherapy trial for children with recurrent medulloblastoma, the most common type of pediatric malignant brain tumor.

“When I look at immunotherapy groups across the country, I cannot think of a single one that has as much effort in pediatric brain tumor immunotherapy as this group,” Sayour says.

Catherine Flores’ research is focused on developing immunotherapy regimens for children with treatment-resistant brain cancers. Photo Credits: Mindy C. Miller

The team of five M.D.s and Ph.D.s in addition to Mitchell — Sayour, Maryam Rahman, Catherine Flores, Jianping Huang and Sridharan Gururangan — came together under — and because of — his leadership.

“As clinicians, we need to bridge the gap with scientists, and scientists need to bridge the gap with clinicians,” says Gururangan, director of pediatric neuro-oncology and the newest member of the team. Mitchell “nurtures the protocol right through and is prepared to go back to the lab and use whatever is happening in the lab to fine-tune the protocol. That is very important.”

Each of the six scientists is leading specific projects to advance new treatments, under an integrated, coordinated effort involving more than 30 nurses, postdoctoral fellows, graduate students and administrative staff members.

There are three phases to their work: A preclinical research team evaluates new approaches before they’re ready to be tested; a development team works to move treatments out of the lab and navigates Food and Drug Administration requirements; and a clinical research team carries out the clinical trials. The teams span at least nine different departments or divisions in the UF College of Medicine and include 16 additional faculty members.

“We work together to make sure that the things we’re advancing within the laboratory setting ultimately have a focus on how we are going to make a difference for patients,” Mitchell says. “One of the distinguishing characteristics of the program here — and a testament to the University of Florida’s capacity and support for the work — is that we are able to take treatments that are literally discovered in the laboratory setting and then bring them to clinical application and make them available for clinical trial evaluation in patients.

“That translational capacity means that patients seek out the University of Florida because the trials are unique in being offered for the first time to patients,” he says. “A center that supports that type of work takes a huge amount of intellectual resources, physical resources, infrastructural resources and financial resources to have an environment where you conduct those trials and do it safely.”

Doing this work has been a long-held dream for Mitchell, whose interest in cancer immunotherapy dates back to when he was an undergrad at Rutgers University. That’s when he first came to understand the concept of a physician-scientist, one who treats as well as develops new treatments, and he was enthralled by the book “The Transformed Cell: Unlocking the Mysteries of Cancer,” by immunotherapy pioneer Steven A. Rosenberg.

Immunotherapy “made a lot of sense to me,” Mitchell says. “The lesson I remember from it is, the immune system should recognize tumors as foreign, and if it did that appropriately, it would reject those cancers and have the ability to remember what it’s rejected, so if it ever comes back, attack it again. That was so different than any other modality for treating a disease I had heard about.”

From then on, Mitchell strove to assemble a personal roadmap toward what he now calls “translational neuro-oncology” or “translational immunotherapy.”

“I had a picture of what an institution needs to have in place as a vision to really make a significant impact in this field,” Mitchell says. “There has to be an institutional vision and a commitment not just from the scientists, not just the physicians, but the medical school, the hospital and the cancer center. The institution needs to be committed to being a leader and making a difference in this area to be successful.

“When I came to visit UF, I saw that those elements were here — all the requisite infrastructure was here to do that, and the commitment and institutional vision to make UF a leader was also here,” he says.

Among those he’s recruited in this effort is Huang, who worked under Rosenberg at the National Cancer Institute for seven years and got to witness complete remissions in patients with metastatic melanoma. “That really inspired me to work hard on the project,” says Huang, now director of clinical laboratory operations for the UF Brain Tumor Immunotherapy Program, also known as BTIP.

Elias Sayour, Catherine Flores, Postdoctoral Associate Kate Candelario and Duane Mitchell in their lab at the McKnight Brain Institute. Photo Credits: Mindy C. Miller

Huang felt drawn to working on brain tumors because survival is so short, she says. With brain tumor, compared with melanoma, immunotherapy is in the early stages. “It’s really a new field, and we can do a lot of things,” she says. “In my heart I think we will do something. I have that hope and confidence that someday we will make a huge difference.”

It can’t come too soon.

Flores, principal investigator of BTIP’s hematopoietic stem cell engineering laboratory, says far too often she has written the following words on a grant application: “Median survival is about a year.”

“It’s very dim,” Flores says. “The standard of care for brain tumors for pediatrics and adults does very little.”

Nonetheless, she feels a great sense of hope for the future.

“I feel like at the rate Dr. Mitchell puts things in clinic, I think we’re definitely getting there,” she says. “Hopefully, with the years to come and with funding and donors and more support, we will be able to overcome the dire need.”


  • Duane Mitchell, Professor of Neurosurgery, co-director of UF’s Preston A. Wells Jr. Center for Brain Tumor Therapy, and head of the Cancer Therapeutics & Immuno-Oncology program at the UF Health Cancer Center

Related Website:

Related Video:

Dr. Duane Mitchell discusses the e use of immunotherapy to treat brain cancers and the importance of philanthropy to innovations in treatment options.

This article was originally featured in the Fall 2016 issue of Explore Magazine.

大番号污app在线下载 秀儿直播污app在线下载 月光直播app污 蓝颜app污 小草莓app污 夏娃直播污app在线下载 小狐仙app污 花狐狸直播app下载手机版 富二代f2短视频污app在线下载 暗夜直播app下载手机版 丝瓜视频污污app在线下载 花姿app污 主播大秀污app在线下载 佳丽直播app下载手机版 成版人茄子视频app污 千层浪污app在线下载 秀儿直播app下载手机版 趣播app污 秀色小抖音app污 成版人音色短视频app下载手机版 秀色直播污app在线下载 秀儿直播污app在线下载 芭乐app污 圣女直播app污 卡哇伊app下载手机版 圣女直播污app在线下载 swag台湾app下载手机版 花心直播app污 台湾swagapp污 乐购直播污app在线下载 豆奶视频app下载手机版 花椒直播app下载手机版 硬汉视频app污 荔枝app污 四虎app下载手机版 d2天堂污app在线下载 黄瓜app下载手机版 花心社区污app在线下载 蜜桃app污 小狐仙app污 年华直播污app在线下载 佳丽直播视频app下载手机版 小蝌蚪app下载手机版 avgo污app在线下载 性福宝app下载手机版 小狐仙视频污app在线下载 午夜直播app下载手机版 猛虎视频污app在线下载 成人快手app下载手机版 红玫瑰直播污app在线下载 花狐狸直播污app在线下载 猛虎视频污app在线下载 茄子app污 快狐app下载手机版 含羞草视频污app在线下载 荔枝app下载手机版 咪哒直播污app在线下载 红高粱直播污app在线下载 青青草app下载手机版 含羞草视频污app在线下载 9uuapp下载手机版 梦露直播app污 可乐视频app下载手机版 香草视频污app在线下载 91视频app污 欢喜视频污app在线下载 享受直播app污 小宝贝直播污app在线下载 向日葵污app在线下载 香蕉直播app污 水仙直播app污 遇见直播app下载手机版 微啪污app在线下载 泡芙短视频app污 泡芙短视频污app在线下载 猛虎视频污app在线下载 草鱼app污 菠萝蜜app下载手机版 s8视频app污 佳丽直播视频污app在线下载 橙子直播污app在线下载 米老鼠直播app污 红颜app下载手机版 夜魅直播app污 考拉直播app污 番茄视频污app在线下载 麻豆传媒污app在线下载 享爱直播污app在线下载 比心直播app下载手机版 麻豆视频app污 宅男之家app污 富二代f2污app在线下载 久草视频app下载手机版 iavbobo污app在线下载 Huluwa污app在线下载 免费黃色直播污app在线下载 小蝌蚪视频app污 好嗨哟直播app污 杏花直播app污 大象视频app下载手机版 小宝贝直播污app在线下载 91直播app下载手机版 夜巴黎直播污app在线下载 年轻人片污app在线下载 主播大秀污app在线下载 金屋藏娇直播间app下载手机版 花样视频app污 秋葵视频app污 fi11含羞草app下载手机版 秀色直播污app在线下载 橙子直播app下载手机版 享受直播app污 主播福利app污 柚子直播app污 猫咪视频app下载手机版 草莓app下载手机版 麻豆传媒视频app污 富二代f2app下载手机版 望月污app在线下载 东京视频app下载手机版 Huluwa污app在线下载 草榴直播app下载手机版 丝瓜视频污app污 蓝精灵直播污app在线下载 粉色视频app下载手机版 小公主直播污app在线下载 BB直播app污 卡哇伊app下载手机版 番茄社区污app在线下载 桃花直播污app在线下载 葡萄视频污app在线下载 茄子直播app下载手机版 蓝颜污app在线下载 BB直播app下载手机版 梦幻直播app下载手机版 水果视频app下载手机版 小蝌蚪视频污app在线下载 富二代f2抖音污app在线下载 压寨直播app污 富二代f2抖音污app在线下载 午夜直播app下载手机版 蓝精灵直播app下载手机版 菠萝蜜app污 久草污app在线下载 朵朵直播app下载手机版 bobo直播app污 大菠萝app污 小小影视app污 美梦视频app下载手机版 合欢视频app污 bobo直播app下载手机版 考拉直播app污 梦露直播app下载手机版 樱桃视频污app在线下载 7秒鱼app污 成版人短视频污app在线下载 青草视频app下载手机版 好嗨哟直播污app在线下载 咪咪直播app污 樱花直播app下载手机版 蜜桃直播污app在线下载 咪哒直播app下载手机版 享爱app污 蜜蜂视频app下载手机版 豌豆直播app下载手机版 免费黃色直播app污 大小姐直播污app在线下载 黄瓜app污 咪哒直播app污 十里桃花直播app污 大秀直播污app在线下载 嘿嘿连载app下载手机版 BB直播app污 依恋直播污app在线下载 午夜直播污app在线下载 梦露直播污app在线下载 云上花app污 彩云直播app污 樱花app污 柠檬直播app下载手机版 九尾狐直播app下载手机版 夜巴黎直播app污 97豆奶视频app下载手机版 灭火卫视污app在线下载 午夜直播间app污 久草视频app下载手机版 硬汉视频app污 套路直播污app在线下载 小仙女污app在线下载 芭乐视频污app在线下载 桃花app污 avgoapp下载手机版 AVBOBOapp下载手机版 九尾狐直播污app在线下载 左手视频app污 享爱app污 秀色直播app下载手机版 樱桃直播app下载手机版 快猫视频污app在线下载 含羞草视频app下载手机版 樱花视频污app在线下载 草榴短视频污app在线下载 铁牛app污 色秀直播污app在线下载 遇见直播污app在线下载 蜜柚直播app下载手机版 梦幻直播app污 红颜app下载手机版 小怪兽app污 小小影视污app在线下载 小蝌蚪视频app污 橙子视频app污 可乐视频app污 铁牛污app在线下载 柚子直播app污 光棍影院污app在线下载 卡哇伊app污 污直播污app在线下载 花狐狸直播污app在线下载 梦露直播app下载手机版 野花视频app污 春水堂app污 bobo直播app污 可乐视频app下载手机版 荔枝视频app下载手机版 樱花雨直播污app在线下载 粉色视频app污 探花直播app污 享爱app污 小怪兽app污 云上花app下载手机版 冈本视频污app在线下载 依恋直播污app在线下载 铁牛视频app下载手机版 卖肉直播app下载手机版 快喵污app在线下载 水蜜桃app污 樱桃视频app污 卖肉直播app污 水蜜桃污app在线下载 台湾swag污app在线下载 夏娃直播app下载手机版 云上花直播污app在线下载 火爆社区app污 小姐姐直播app污 花椒直播app污 7秒鱼app污 麻豆传媒直播app下载手机版 含羞草实验研究所污app在线下载 合欢视频app下载手机版 享爱污app在线下载 樱桃视频app污 蓝精灵直播app污 成版人茄子视频app下载手机版 小姐姐直播app污 泡泡直播app下载手机版 香草成视频人app污 小仙女app污 葫芦娃app下载手机版 桃花app污 小奶猫app污 红楼直播app下载手机版 月亮直播app污 番茄社区污app在线下载 小可爱app下载手机版 趣播app下载手机版 香草成视频人app污 木瓜视频app下载手机版 污软件污app在线下载 最污直播app下载手机版 猛虎视频污app在线下载 后宫视频污app在线下载 烟花直播污app在线下载 朵朵直播app下载手机版 花心社区app污 酷咪直播污app在线下载 小仙女app下载手机版 金鱼直播app下载手机版 Kitty直播app污 幸福宝app污 免费黃色直播app下载手机版 享受直播app污 花姿直播app下载手机版 微杏app下载手机版 蜜橙视频污app在线下载 s8视频app下载手机版 恋人直播app污 繁花直播污app在线下载 比心直播app下载手机版 微杏app污 朵朵直播污app在线下载 七仙女直播污app在线下载 男人本色西瓜视频app下载手机版 蓝颜污app在线下载 遇见直播app下载手机版 梦幻直播app下载手机版 小猪视频app污 丝瓜app污 小公主直播app污 小奶猫app下载手机版 快猫视频污app在线下载 大番号app污 小天仙直播污app在线下载 6房间视频直播污app在线下载 丝瓜草莓视频app污 暗夜直播app下载手机版 花样视频app污 夏娃直播app下载手机版 AVnightapp污 抖阴视频app污 小公主直播污app在线下载 暗夜直播app下载手机版 后宫app下载手机版 夜狼直播app污 酷咪直播app污 菠萝蜜视频app下载手机版 逗趣直播app下载手机版 小v视频app下载手机版 iAVBOBOapp污 小优污app在线下载 性福宝app下载手机版 花仙子直播污app在线下载 bobo直播污app在线下载 梦幻直播污app在线下载 九尾狐视频app污 本色视频app污 啪嗒视频污app在线下载 迷雾直播app污 合欢视频app污 草莓直播app下载手机版 豆奶视频app下载手机版 麻豆传媒映画app下载手机版 七仙女直播污app在线下载 小仙女app污 蝴蝶直播污app在线下载 水晶直播污app在线下载 含羞草app下载手机版 宅男之家app下载手机版 探花直播污app在线下载 欢喜视频污app在线下载 午夜神器污app在线下载 彩色直播app污 水晶直播app污 烟花巷直播app污 趣播app污 91视频污app在线下载 套路直播污app在线下载 夜夜直播app下载手机版 快猫视频app污 麻豆传媒视频污app在线下载 男人本色西瓜视频污app在线下载 久草视频app下载手机版 小公主直播app污 快猫短视频污app在线下载 快猫视频污app在线下载